BDP 650/665 maleimide
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 18480 | 1 mg | $125 | in stock | |
| 28480 | 5 mg | $260 | in stock | |
| 48480 | 25 mg |
$510
|
in stock | |
| 58480 | 50 mg |
$895
|
in stock | |
| 68480 | 100 mg |
$1490
|
in stock |
BDP 650/665 is a bright, red emitting fluorophore for Cyanine5 (Cy5) channel. The dye has a high molar extinction coefficient, and a good emission quantum yield. The dye is moderately hydrophobic, but can be used to label biomolecules in aqueous environment, so it is a good alternative to Cy5.
Maleimide is a thiol reactive group. The compound can be used for the labeling of cysteine residues of proteins and peptides, among other SH-containing molecules.
Absorption and emission spectra of BDP 650/665
Customers also purchased with this product
Cyanine3 maleimide
Cyanine3 maleimide is a thiol mono-reactive dye for protein labeling.DiR, lipophilic tracer
Near-infrared fluorescent lipophilic dye for membrane labeling and cell tracing.6-Carboxy-H2DCFDA (6-carboxy-2',7'-dichlorodihydrofluorescein)
A reagent for detecting reactive oxygen species (ROS) in living cells. This carboxylated H2DCFDA analog has two additional negative charges that impede its leakage out of the cell.General properties
| Appearance: | dark colored solid |
| Mass spec M+ increment: | 555.2 |
| Molecular weight: | 555.34 |
| Molecular formula: | C29H24N5BF2O4 |
| Solubility: | good in DMF, DMSO, low in water |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 649 |
| ε, L⋅mol−1⋅cm−1: | 94000 |
| Emission maximum, nm: | 667 |
| Fluorescence quantum yield: | 0.52 |
| CF260: | 0.04 |
| CF280: | 0.04 |
Product citations
- Massó-Vallés, D.; Beaulieu, M.-E.; Jauset, T.; Giuntini, F.; Zacarías-Fluck, M. F.; Foradada, L.; Martínez-Martín, S.; Serrano, E.; Martín-Fernández, G.; Casacuberta-Serra, S.; Castillo Cano, V.; Kaur, J.; López-Estévez, S.; Morcillo, M. Á.; Alzrigat, M.; Mahmoud, L.; Luque-García, A.; Escorihuela, M.; Guzman, M.; Arribas, J.; Serra, V.; Larsson, L.-G.; Whitfield, J. R.; Soucek, L. MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer Research Communications, 2022, 2(2), 110–130. doi: 10.1158/2767-9764.CRC-21-0103
BDP® is a trademark of Lumiprobe
The count of items is incorrect.
Your cart is empty
$ 
